Search results
FDA approves Boehringer Ingelheim’s Cyltezo for inflammatory ailments
Pharmaceutical Technology via Yahoo Finance· 2 hours agoThe US Food and Drug Administration (FDA) has approved Boehringer Ingelheim's high-concentration,...
FDA, doctors warn about compounded Ozempic. What we found at metro weight loss clinics
WFXT via Yahoo News· 11 hours agoIt’s a popular drug that millions of people are taking to lose weight, but the federal government...
FDA approves asthma drug for treating food allergies
WOOD via Yahoo News· 7 days agoA drug newly approved by the Food and Drug Administration to reduce the risk of allergic reactions from food could bring relief to millions across the...
FDA approves Libervant for young epilepsy patients By Investing.com
Investing.com· 15 hours agoAquestive Therapeutics , Inc. (NASDAQ: NASDAQ:AQST) announced that the U.S. Food and Drug...
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
Reuters· 10 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition ...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 2 hours agoThe more significant issue at hand for Fouad, however, is that when it comes to discussions held...
FDA approves over-the-counter sales of Narcan. But would you know what to do to save a life?
WPXI· 12 hours agoIn Pennsylvania, accidental drug overdoses are now the number one cause of death for people under...
Wegovy & other GLP-1 drugs to get coverage under Medicare Part D
AARP· 18 hours agoThe FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks ...
Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation
Pharmaceutical Technology via Yahoo Finance· 19 hours agoThe US Food and Drug Administration (FDA) has approved an alternative formulation for Neurocrine...
FDA Issues Final Rule Regulating Many Laboratory-Developed Tests as Medical Devices
The National Law Review· 19 hours agoOn April 29, 2024, the US Food and Drug Administration (FDA) issued the long-awaited final rule...